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• Behavioral health medication utilization in the pediatric 
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Targeted Prescriber Telephone Outreach





•	 Prescribers	for	members	<3 years old 	
•	 Prescribers	for	all	members	<18 years old 
•	 Massachusetts	and	border	states	only	
Prior Authorization (PA) Requirements
PA	requirements	for	members	<3	years	old
Any	pharmacy	claim	for	an	alpha2	agonist	or	cerebral	stimulant
PA	requirements	for	members		<6	years	old
Any	pharmacy	claim	for	an	antipsychotic,	antidepressant,	atomoxetine,	benzodiazepine,	
buspirone,	hypnotic,	or	mood	stabilizer	
PA	requirements	for	members		<18	years	old
Type	of	Polypharmacy Number	of	Prescriptions	and	Duration
Antidepressant 2	or	more	for	≥60	days	within	a	90	day	period
Antipsychotic 2	or	more	for	≥60	days	within	a	90	day	period
Benzodiazepine 2	or	more	for	≥60	days	within	a	90	day	period
Cerebral	stimulant 2	or	more	for	≥60	days	within	a	90	day	period
Mood	stabilizer 3	or	more	for	≥60	days	within	a	90	day	period
Behavioral	health	medication	 4	or	more	within	a	60	day	period
Total	number	of	prescribers	=	79 Total	number	of	prescribers	=	123
